Literature DB >> 8116619

Localization of predisposition to Hodgkin disease in the HLA class II region.

W Klitz1, C L Aldrich, N Fildes, S J Horning, A B Begovich.   

Abstract

Molecular typing of HLA class II loci has been performed on a sample of 196 patients with Hodgkin lymphoma. Division of patients into two histological categories--nodular sclerosing Hodgkin disease versus all other types--shows significant overall association of the nodular sclerosing group with the HLA class II region. Haplotypes and alleles defined for the four loci typed--DRB1, DQA1, DQB1, and DPB1--were present in both excess and deficit in the nodular sclerosing sample. Some of the effects are attributable to particular DRB1 and DQB1 alleles, while other effects are best explained by haplotypes marking the entire class II region. The latter effects might be due to variation in additional, as-yet-unexamined loci in the class II region or to particular combinations of alleles from two or more loci. These data also explain why earlier studies showed HLA linkage but not association, and they substantiate the specific involvement of the immune system in certain neoplastic diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8116619      PMCID: PMC1918115     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  Genetic diversity within the HLA class II region: ten new DPB1 alleles and their population distribution.

Authors:  P V Moonsamy; V C Suraj; T L Bugawan; R K Saiki; M Stoneking; J Roudier; M M Magzoub; A V Hill; A B Begovich
Journal:  Tissue Antigens       Date:  1992-09

2.  Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells.

Authors:  M S Malnati; M Marti; T LaVaute; D Jaraquemada; W Biddison; R DeMars; E O Long
Journal:  Nature       Date:  1992-06-25       Impact factor: 49.962

3.  Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells.

Authors:  H Herbst; F Dallenbach; M Hummel; G Niedobitek; S Pileri; N Müller-Lantzsch; H Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Map of the human MHC.

Authors:  J Trowsdale; J Ragoussis; R D Campbell
Journal:  Immunol Today       Date:  1991-12

5.  Polymorphism, recombination, and linkage disequilibrium within the HLA class II region.

Authors:  A B Begovich; G R McClure; V C Suraj; R C Helmuth; N Fildes; T L Bugawan; H A Erlich; W Klitz
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

6.  HLA-DR, DQ and DP typing using PCR amplification and immobilized probes.

Authors:  H Erlich; T Bugawan; A B Begovich; S Scharf; R Griffith; R Saiki; R Higuchi; P S Walsh
Journal:  Eur J Immunogenet       Date:  1991 Feb-Apr

7.  Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease.

Authors:  T C Wu; R B Mann; P Charache; S D Hayward; S Staal; B C Lambe; R F Ambinder
Journal:  Int J Cancer       Date:  1990-11-15       Impact factor: 7.396

8.  Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.

Authors:  G Pallesen; S J Hamilton-Dutoit; M Rowe; L S Young
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

9.  Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.

Authors:  R Khanna; S R Burrows; M G Kurilla; C A Jacob; I S Misko; T B Sculley; E Kieff; D J Moss
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

10.  Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

Authors:  R J Murray; M G Kurilla; J M Brooks; W A Thomas; M Rowe; E Kieff; A B Rickinson
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

View more
  21 in total

1.  Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles.

Authors:  S Chaudhuri; A Cariappa; M Tang; D Bell; D A Haber; K J Isselbacher; D Finkelstein; D Forcione; S Pillai
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  Multi-locus HLA class I and II allele and haplotype associations with follicular lymphoma.

Authors:  C F Skibola; N K Akers; L Conde; M Ladner; S K Hawbecker; F Cohen; F Ribas; H A Erlich; D Goodridge; E A Trachtenberg; M T Smith; P M Bracci
Journal:  Tissue Antigens       Date:  2012-02-02

Review 3.  Familial predisposition and genetic risk factors for lymphoma.

Authors:  James R Cerhan; Susan L Slager
Journal:  Blood       Date:  2015-09-24       Impact factor: 22.113

4.  The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families.

Authors:  J A Noble; A M Valdes; M Cook; W Klitz; G Thomson; H A Erlich
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

5.  Association mapping of disease loci, by use of a pooled DNA genomic screen.

Authors:  L F Barcellos; W Klitz; L L Field; R Tobias; A M Bowcock; R Wilson; M P Nelson; J Nagatomi; G Thomson
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

6.  A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci.

Authors:  Gabrielle S Sellick; Emily L Webb; Ruth Allinson; Estella Matutes; Martin J S Dyer; Viggo Jonsson; Anton W Langerak; Francesca R Mauro; Stephen Fuller; James Wiley; Matthew Lyttelton; Vincenzo Callea; Martin Yuille; Daniel Catovsky; Richard S Houlston
Journal:  Am J Hum Genet       Date:  2005-08-02       Impact factor: 11.025

7.  A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32.

Authors:  Wendy Cozen; Dalin Li; Timothy Best; David J Van Den Berg; Pierre-Antoine Gourraud; Victoria K Cortessis; Andrew D Skol; Thomas M Mack; Sally L Glaser; Lawrence M Weiss; Bharat N Nathwani; Smita Bhatia; Fredrick R Schumacher; Christopher K Edlund; Amie E Hwang; Susan L Slager; Zachary S Fredericksen; Louise C Strong; Thomas M Habermann; Brian K Link; James R Cerhan; Leslie L Robison; David V Conti; Kenan Onel
Journal:  Blood       Date:  2011-11-15       Impact factor: 22.113

8.  Reproductive failure and the major histocompatibility complex.

Authors:  K Jin; H N Ho; T P Speed; T J Gill
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

Review 9.  Genetic susceptibility to lymphoma.

Authors:  Christine F Skibola; John D Curry; Alexandra Nieters
Journal:  Haematologica       Date:  2007-07       Impact factor: 9.941

Review 10.  The genetics of familial lymphomas.

Authors:  Rina Siddiqui; Kenan Onel; Flavia Facio; Kenneth Offit
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.